ESCITALOPRAM OXALATE | N021365 | ABBVIE INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Lachman Consultant Services, Inc. - Citizen Petition FDA-2007-P-0297 · 6 docket documents Lachman Consultant Services, Inc. filed this petition on behalf of a client requesting the FDA declare that Escitalopram Oxalate Orally Dissolving Film Strips in 5 mg, 10 mg, and 20 mg strengths is suitable for consideration in an abbreviated new drug application under Section 505(j)(2)(C), using Le | Other | 2008-05-22 | Withdrawn | — |
Source: Regulations.gov. FDA citizen petitions matched by application number.
| Code | Date | Status |
|---|---|---|
| NPP | May 12, 2026 | Expired |